| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd, Inc. (TXMD) has 4 insiders with recent SEC Form 4 filings, including 4 buys and 1 sell. TXMD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 67.5K | $133.6K | - | |
| ? | 23.2K | $45.9K | - | |
| ? | 8.5K | $16.8K | - | |
| ? | 8.5K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 20, 2015 | Krassan Mitchell | EVP, Chief Strategy Officer | Sale+OE | 60,000 | $6.56 | $393,354.00 | -100% | |
| May 12, 2015 | Russell Angus C. | Director | Buy | 35,000 | $6.15 | $215,316.50 | New | |
| May 11, 2015 | Thompson Tommy G50 | Director, Chairman | Buy | 6,000 | $6.09 | $36,540.00 | +0.9% | |
| May 8, 2015 | Carroll J Martin53 | Director | Buy | 10,000 | $6.11 | $61,100.00 | New |